Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.975
Delayed Data
As of Apr 29
 -0.025 / -2.50%
Today’s Change
0.46
Today|||52-Week Range
4.10
-19.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues1.4M4.0M6.7M6.0M
 
 
 
 
 
Depreciation And Amortization46.0K70.0K62.0K66.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.3M9.5M11.4M9.4M
 
 
 
 
 
Research And Development3.7M6.5M8.3M6.6M
 
 
 
 
 
Total Operating Expenses6.4M9.6M11.4M9.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.0M-5.6M-4.7M-3.5M
 
 
 
 
 
Extraordinary Credit465.0K0.00131.0K0.00
 
 
 
Extraordinary Charge0.00-429.0K0.000.00
 
 
Other Expenses-39.0K-7.0K-14.0K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-6.0M-4.6M-1.7M
 
 
 
 
 
Net Income-4.5M-6.0M-4.6M-1.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.7M23.5M28.5M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted22.7M23.5M28.5M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.26-$0.16-$0.06
 
 
 
 
 
EPS Diluted-$0.20-$0.26-$0.16-$0.06